Report for Naoi M

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition - Youdim_2005_J.Neurosci.Res_79_172
Author(s) : Youdim MB , Bar Am O , Yogev-Falach M , Weinreb O , Maruyama W , Naoi M , Amit T
Ref : Journal of Neuroscience Research , 79 :172 , 2005
Abstract : Youdim_2005_J.Neurosci.Res_79_172
ESTHER : Youdim_2005_J.Neurosci.Res_79_172
PubMedSearch : Youdim_2005_J.Neurosci.Res_79_172
PubMedID: 15573406

Title : Poster (57) A novel neuroprotective trifunctional cholinesterase inhibitor derivative of the antiparkinson drug, rasagiline, for treatment of dementia and lewy body disease co-morbid with depression -
Author(s) : Youdim MB , Sagi Y , Derigus N , Naoi M , Maruyama W , Amit T , Falash-Yogev M , Weinstock M
Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :351 , 2004
PubMedID:

Title : Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor - Maruyama_2003_Neurosci.Lett_341_233
Author(s) : Maruyama W , Weinstock M , Youdim MB , Nagai M , Naoi M
Ref : Neuroscience Letters , 341 :233 , 2003
Abstract : Maruyama_2003_Neurosci.Lett_341_233
ESTHER : Maruyama_2003_Neurosci.Lett_341_233
PubMedSearch : Maruyama_2003_Neurosci.Lett_341_233
PubMedID: 12697291